View Press Release
View PowerPoint Presentation
Theodore Hong, MD
To evaluate the addition of liver-directed radiation therapy to chemotherapy with respect to overall survival (OS) for patients with unresectable, localized intrahepatic cholangiocarcinoma.
Pathologically (histologically or cytologically) proven diagnosis of IHC without distant extrahepatic metastasis
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website